Bozeman, MT, June 01, 2014 --(PR.com
)-- ACAM, the pre-eminent education and certification organization in chelation therapy, will present the world’s first live webinars on chelation therapy.
The American College for Advancement in Medicine is the first in the world to present a live webinar-based course on Chelation therapy.
When: Tuesday June 3rd from 7pm -9 pm EST.
The course will run live for 4 weeks and will feature renowned speakers, including Dr. Tony Lamas who is the lead investigator in the TACT (Trial to Assess Chelation Therapy) Study. The webinars will be archived for further reference and ACAM will also be offering in person, hands on practicums at multiple locations throughout the USA.
Chelation therapy is an intravenous infusion of EDTA, a semi-synthetic amino acid that binds heavy metals and removes them from the body. A recent study published in the Journal of the American Medical Association (JAMA) showed chelation therapy has statistically significant benefit in preventing secondary cardiac events in patients with heart disease and notably in diabetic patients.
For further information and to participate go to www.acam.org.
Media Contact: Dana Cohen, MD, program director: email@example.com